MERCK Kommanditgesellschaft auf Aktien – OTC:MKKGY

Add to watchlist

$25.91

-3.16

-10.9%

Market closed

Open in about 6 hours

-13.38%

month

-13.38%

quarter

-8.18%

year

Market Cap	88.61B
Enterprise value	56.65B

P/E	4.50
EV/Sales	2.70
EV/EBITDA	9.71
Price/Sales	2.85
Price/Book	0.42
PEG ratio	-0.57
EPS	6.27

Revenue	20.82B
EBITDA	5.88B
Income	2.72B
Revenue Q/Q	-3.26%
Revenue Y/Y	-6.74%

Profit margin	12.86%
Oper. margin	18.09%
Gross margin	58.6%
EBIT margin	18.09%
EBITDA margin	28.26%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Profit margin
Jun 2023	5.30B	704M	13.28%
Sep 2023	5.17B	739M	14.29%
Dec 2023	5.22B	586M	11.22%
Mar 2024	5.12B	694M	13.55%

MERCK Kommanditgesellschaft auf Aktien Financials Estimate

Q Y

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Analyst Estimates
Dec 2023	5.22B	586M	11.22%
Mar 2024	5.12B	694M	13.55%
Sep 2025	6.54B	0
Dec 2025	6.73B	0

Analysts Price target
Financials & Ratios estimates

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Payout ratio
Payout ratio	70.44%

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Dividend Yield
2019	7.37%
2020	5.56%
2021	3.76%
2022	6.1%
2023	9.16%

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Debt to assets
Jun 2023	48782000000	22.01B	45.12%
Sep 2023	49906000000	21.61B	43.3%
Dec 2023	49122000000	22.36B	45.53%
Mar 2024	49504000000	21.43B	43.29%

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Cash Flow
Jun 2023	622M	140M	-580M
Sep 2023	1.25B	-350M	-302M
Dec 2023	1.05B	-451M	-974M
Mar 2024	1.03B	-689M	-107M

MERCK Kommanditgesellschaft auf Aktien alternative data

MERCK Kommanditgesellschaft auf Aktien
Employees

MERCK Kommanditgesellschaft auf Aktien (OTC:MKKGY): Employee count
Sep 2023	63,712
Oct 2023	63,712
Nov 2023	63,712
Dec 2023	63,297
Jan 2024	63,297
Feb 2024	63,297
Mar 2024	62,908
Apr 2024	62,908
May 2024	62,908
Jun 2024	62,345
Jul 2024	62,345

MERCK Kommanditgesellschaft auf Aktien
Latest News

Wednesday, 27 November 2024
10:40	Is Merck KGaA (MKKGY) Stock Undervalued Right Now?	zacks.com
Thursday, 14 November 2024
15:29	Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript	seekingalpha.com
Monday, 11 November 2024
10:45	Is Merck KGaA (MKKGY) a Great Value Stock Right Now?	zacks.com
Sunday, 20 October 2024
23:14	AI is driving semiconductor industry, says CEO Electronics at Merck KgaA	youtube.com
Saturday, 3 August 2024
13:50	Merck KGaA (MKGAF) Q2 2024 Earnings Call Transcript	seekingalpha.com
Thursday, 4 July 2024
03:39	Merck KGaA: The Drop Makes The Upside All The Sweeter	seekingalpha.com
Tuesday, 25 June 2024
11:20	Merck KGaA shares slump on neck cancer trial failure	proactiveinvestors.com
Monday, 24 June 2024
16:34	Merck KGaA, Darmstadt, Germany, Provides Update on Phase III TrilynX Study in Locally Advanced Head and Neck Cancer	businesswire.com
Thursday, 23 May 2024
17:00	Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024	businesswire.com
Wednesday, 15 May 2024
12:31	Merck KGaA (MKGAF) Q1 2024 Earnings Call Transcript	seekingalpha.com
01:30	Merck KGaA's Q1 adjusted profit declines less than feared	Reuters
Thursday, 7 March 2024
12:02	Merck KGaA (MKGAF) Q4 2023 Earnings Call Transcript	Seeking Alpha
01:09	Merck KGaA forecasts return to organic earnings growth in 2024	Reuters
Wednesday, 6 December 2023
11:25	Merck KGaA's experimental MS drug fails in late stage trials sending shares tumbling	Proactive Investors
Tuesday, 5 December 2023
15:53	Merck KGaA says MS drug fails in late-stage trials	Reuters
Sunday, 12 November 2023
20:42	Evotec: Attractive Spec 'Buy', But Merck KGaA Is Still Better	Seeking Alpha
Thursday, 9 November 2023
01:03	Merck KGaA Q3 earnings down 20% on weak biotech, electronics demand	Reuters
Monday, 30 October 2023
04:45	Merck KGaA widens work on 'DNA damage' drugs in deal with China's Hengrui	Reuters
Thursday, 19 October 2023
02:08	Merck KGaA says MS drug has blockbuster potential; key data expected in December	Reuters
02:03	Merck KGaA raises prospect of return to sales growth next year	Reuters
Wednesday, 20 September 2023
09:13	Exscientia stock surges on Merck KGaA partnership	Proactive Investors
07:50	Exscientia's stock rockets toward a record gain after AI-driven drug discovery collaboration with Germany's Merck KGaA	Market Watch
Sunday, 13 August 2023
11:40	Merck KGaA: Expect A 10% CAGR EBITDA Increase In 2024-2025	Seeking Alpha
Saturday, 5 August 2023
07:21	Merck KGaA (MKGAF) Q2 2023 Earnings Call Transcript	Seeking Alpha
Thursday, 11 May 2023
09:44	Strong start of the year in our health care department, says Merck KGaA CFO	CNBC International TV
Sunday, 22 January 2023
22:53	Ranking The Diversified Healthcare Giants	Seeking Alpha
Wednesday, 4 January 2023
03:39	Trim Big Pharma For Merck KgaA	Seeking Alpha
Thursday, 10 November 2022
16:03	MERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belen Garijo on Q3 2022 Results - Earnings Call Transcript	Seeking Alpha
Friday, 13 May 2022
10:38	Merck KGaA (MKGAF) CEO Belén Garijo on Q1 2022 Results - Earnings Call Transcript	Seeking Alpha

Ideas & Opinions

Seeking Alpha 15 Aug 2025

Bruker: Former Academia Customer Strength, Now Incredible Weakness
Seeking Alpha 25 Jul 2025

Merck KGaA: The Undervaluation Is Now Close To 13-Year Lows
Seeking Alpha 4 Jul 2024

Merck KGaA: The Drop Makes The Upside All The Sweeter
Seeking Alpha 10 Apr 2024

908 Devices: Rare Early-Stage Bioprocess Investment Opportunity
Seeking Alpha 10 Dec 2023

Week In Review: Abbisko Sells China Rights For CSF-1R Inhibitor To Merck In $605M Deal
Seeking Alpha 13 Nov 2023

Evotec: Attractive Spec 'Buy', But Merck KGaA Is Still Better
Seeking Alpha 5 Nov 2023

Week In Review: Hengrui Out-Licenses Next-Gen PARP1 To Merck KGaA For $1.7B
Seeking Alpha 20 Sep 2023

Exscientia: Merck Deal Further Cements Industry Positioning, Reiterate Buy
Seeking Alpha 13 Aug 2023

Merck KGaA: Expect A 10% CAGR EBITDA Increase In 2024-2025
Seeking Alpha 25 May 2023

Roche, With Ocrevus And Fenebrutinib Advancement, Should Be Top MS Contender

Frequently Asked Questions (FAQ)

What's the price of MERCK Kommanditgesellschaft auf Aktien stock today?

One share of MERCK Kommanditgesellschaft auf Aktien stock can currently be purchased for approximately $25.91.
When is MERCK Kommanditgesellschaft auf Aktien's next earnings date?

Unfortunately, MERCK Kommanditgesellschaft auf Aktien's (MKKGY) next earnings date is currently unknown.
Does MERCK Kommanditgesellschaft auf Aktien pay dividends?

Yes, MERCK Kommanditgesellschaft auf Aktien pays dividends and its trailing 12-month yield is 1.69% with 70% payout ratio. The last MERCK Kommanditgesellschaft auf Aktien stock dividend of undefined was paid on 8 Sep 2025.
How much money does MERCK Kommanditgesellschaft auf Aktien make?

MERCK Kommanditgesellschaft auf Aktien has a market capitalization of 88.61B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 5.57% to 20.99B US dollars.
What is MERCK Kommanditgesellschaft auf Aktien's stock symbol?

MERCK Kommanditgesellschaft auf Aktien is traded on the OTC under the ticker symbol "MKKGY".
What is MERCK Kommanditgesellschaft auf Aktien's primary industry?

Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
How do i buy shares of MERCK Kommanditgesellschaft auf Aktien?

Shares of MERCK Kommanditgesellschaft auf Aktien can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does MERCK Kommanditgesellschaft auf Aktien have?

As Jul 2024, MERCK Kommanditgesellschaft auf Aktien employs 62,345 workers, which is 1% less then previous quarter.
When MERCK Kommanditgesellschaft auf Aktien went public?

MERCK Kommanditgesellschaft auf Aktien is publicly traded company for more then 17 years since IPO on 13 Nov 2007.
What is MERCK Kommanditgesellschaft auf Aktien's official website?

The official website for MERCK Kommanditgesellschaft auf Aktien is merckgroup.com.
How can i contact MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien can be reached via phone at +49 6151 720.

MERCK Kommanditgesellschaft auf Aktien

merckgroup.com

Exchange:

OTC

Full time employees:

63,723

Industry:

Drug Manufacturers—Specialty & Generic

Sector:

Healthcare

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

+49 6151 720

Frankfurter Strasse 250
Darmstadt, 64293

:
ISIN: US5893392093
: